SOURCE: Neuroscience Therapy Corp.

March 20, 2007 13:09 ET

Neuroscience Therapy Corp. Announces Name Change to Nashville Records

NASHVILLE, TN -- (MARKET WIRE) -- March 20, 2007 -- Nashville Records, Inc., a Tennessee Corporation and Neuroscience Therapy Corp. (PINKSHEETS: NPYC):

The Share Purchase Agreement entered into on December 7, 2005 between the shareholders of Neuroscience Therapy Corporation, a Washington corporation and Alpaca Enterprises Ltd., a Nevada corporation, and pursuant to which the name of Alpaca was subsequently changed to Neuroscience Therapy Corporation, was rescinded in its entirety by a Rescission Agreement dated October 11, 2006. The Parties to the Rescission Agreement are all the prior stockholders of Neuroscience Washington, Neuroscience Technology Corporation and Robert Munro, who was the controlling stockholder of Alpaca prior to the acquisition.

In connection with the rescission Randolph A. Turpin and Michael H. Schuttemeyer appointed Dale Propp and Frank Rossi as additional directors of the corporation and agreed to resign. Neither Turpin nor Schuttemeyer have taken any part in managing the affairs of the corporation since October 29, 2006 and both have now resigned.

On February 12, 2007 a Share Purchase Agreement was executed by which Neuroscience Therapy Corporation agreed to acquire 100% of the issued and outstanding shares of Nashville Records, Inc., a Tennessee Corporation. Nashville Records, Inc. is a record label headquartered in its name city which is engaged in the production and distribution of recorded country music. It has a roster of officers and key advisors with long histories of successful operations in the country music business.

Messrs. Propp and Rossi have now resigned as the Board of Directors of the Company and appointed the following persons to fulfill their unexpired terms as officers and directors.

Gene Sibbett   Director, President
Tim Riley      Director, Vice President of Creative Services and Marketing
Terri Sibbett  Director, Secretary and Treasurer
The Board of Directors and a majority of the Company's outstanding common shares have consented in writing to the adoption of resolution changing the name of the corporation from Neuroscience Therapy Corporation to Nashville Records, Inc. by which it will hereafter be known. Filings necessary to formally change the name are in process.

Legal Notice Regarding Forward-Looking Statements

The statements in this press release that relate to the Company's expectations with regard to the future impact on the Company's results are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.

Contact Information